Cystic Fibrosis Clinical Trial
Official title:
Adherence to Airway Clearance. Novel Approaches to Improving Adherence
An airway clearance technique (ACT) is one of the core treatments for children with chronic lung diseases who are unable to clear their secretions effectively. Unfortunately adherence to performing an ACT is low with a reported rate between 40 - 70%. Up to the present, there has been no way to objectively measure adherence to an ACT. With new technology, it is now feasible to connect an electronic manometer to an airway clearance device to objectively measure how often the child is actually performing their ACT. The first part of this proposed study is to objectively measure adherence against reported adherence over a 4 month period. During the second 4 months a video game will be added to the digital manometer which only operates if participants are performing their ACT properly. Adherence will again be measured.
Background:- Airway clearance using an airway clearance technique (ACT) is one of the core
treatments for children with chronic lung diseases such as cystic fibrosis, periciliary
dyskinesia, and non-CF bronchiectasis who are unable to clear their secretions effectively.
One of the most frequently used ACTs is called positive expiratory pressure (PEP) which uses
a mask to produce a back pressure in the lungs getting air behind the mucus to mobilize it
up the airways. Unfortunately adherence to performing an ACT is low with a reported rate
between 40 - 70%. Up to the present, there has been no way to objectively measure adherence
to an ACT. However, with new technology, it is now feasible to connect an electronic device
to the PEP mask to objectively measure how often the child is actually performing their ACT.
This proposed study would be the first study to objectively measure adherence against
reported adherence.
Purpose:
1. To objectively measure adherence, using an electronic manometer attached to a PEP mask,
against reported adherence.
2. Secondly, to objectively measure adherence after connecting the electronic manometer to
an age appropriate video game designed to operate only if the PEP mask is used
properly.
The hypothesis is that actual adherence is lower than reported adherence, and that by using
a video game as a feedback mechanism while performing PEP, adherence will be improved.
Methodology:-20 subjects with either a diagnosis of cystic fibrosis or non CF
bronchiectasis, between the ages of 6 - 12 years old will be recruited into this study.
Subjects will be their own control, in that their reported adherence will be measured
against their actual adherence. After enrollment, subjects will be provided with an
electronic device which connects to the pressure port of their PEP mask. They will be told
that the device attached to the PEP Mask pressure port will measure pressure. Subjects will
be asked to continue using their PEP Mask as prescribed for 4 months referred to as period
one. During this time the electronic device will collect data on pressure and how often and
when the PEP mask is used. In addition the subject or parent will be asked to keep a log
book of when and how often they did their PEP Mask.
At the end of 4 months, during a second 4 month period, the electronic manometer will be
connected to software which will allow the subject to play video games operated by correct
breathing through the PEP Mask. During this period actual adherence captured through the
electronic device will be measured against reported adherence for this period and also to
actual adherence measured during the first 4 month period.
Primary outcome is rate of adherence to prescribed therapy, measured between reported and
objectively measured adherence during the first 4 month period. During the second 4 month
period, rate of adherence will be compared to rate of adherence during the first 4 month
period. Secondary outcome is change in FEV1 from period one to period two. It is hoped that
by using fun video games while performing airway clearance, adherence will be improved.
;
Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04696198 -
Thoracic Mobility in Cystic Fibrosis Care
|
N/A | |
Completed |
NCT00803205 -
Study of Ataluren (PTC124™) in Cystic Fibrosis
|
Phase 3 | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03601637 -
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
|
Phase 3 | |
Terminated |
NCT02769637 -
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
|
||
Recruiting |
NCT06012084 -
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
|
N/A | |
Recruiting |
NCT06032273 -
Lung Transplant READY CF 2: CARING CF Ancillary RCT
|
N/A | |
Recruiting |
NCT06030206 -
Lung Transplant READY CF 2: A Multi-site RCT
|
N/A | |
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Recruiting |
NCT05392855 -
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
|
N/A | |
Recruiting |
NCT04039087 -
Sildenafil Exercise: Role of PDE5 Inhibition
|
Phase 2/Phase 3 | |
Recruiting |
NCT04056702 -
Impact of Triple Combination CFTR Therapy on Sinus Disease.
|
||
Completed |
NCT04038710 -
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
|
||
Completed |
NCT04058548 -
Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation
|
N/A | |
Completed |
NCT03637504 -
Feasibility of a Mobile Medication Plan Application in CF Patient Care
|
N/A | |
Recruiting |
NCT03506061 -
Trikafta in Cystic Fibrosis Patients
|
Phase 2 | |
Completed |
NCT03566550 -
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
|
||
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Recruiting |
NCT04010253 -
Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic Fibrosis
|
N/A |